SCHEMBL23348232

SCHEMBL23348232

Cc1cc(C)c(-c2ccc3c(c2)c2ccc(-c4ccccc4)cc2n3-c2cc(-n3c4ccc(-c5c(C)cc(C)cc5C)cc4c4ccc(-c5c(C)cc(C)cc5C)cc43)c(F)c(C#N)c2F)c(C)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 2/20 0.33
PDE9A O76083 1/20 0.33
KDM5B Q9UGL1 3/20 0.32
GRIA2 P42262 3/20 0.32
GRIA4 P48058 3/20 0.32
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.32
KDM4A O75164 2/20 0.31
ALDH1A1 P00352 3/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
PSMB5 P28074 1/20 0.30
DHODH Q02127 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348308 0.90 KDM5B (0.34) KDM5BGRIA2GRIA4KDM4EKDM4A
SCHEMBL23348407 0.87 PDE1C (0.35) PDE1CPDE9AKDM5BGRIA2GRIA4
SCHEMBL23348524 0.83 PGR (0.35) GRIA2GRIA4KDM4EALDH1A1
SCHEMBL23348309 0.82 KCNJ5 (0.32)
SCHEMBL23348227 0.82 KCNJ5 (0.32) KDM4E
SCHEMBL23348237 0.82 CHEK1 (0.31)
SCHEMBL23348226 0.82 SMN1; SMN2 (0.36) PDE1CPDE9AKDM5BKDM4EGAA
SCHEMBL23348235 0.82 KDM4E (0.34) GRIA2GRIA4KDM4EALDH1A1
SCHEMBL23348238 0.82 CHEK1 (0.36)
SCHEMBL23348415 0.81 ALDH1A1 (0.34) PDE1CPDE9AKDM4EALDH1A1PSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed
US-9527885-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CCND2, CCND1, CRY1 PDE1C 4812/4885PDE9A 3859/4885KDM5B 3881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.